| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Sa | Auna Sells 25% Stake to Sojitz as Regional Health Needs Expand | 2 | Mexico Business News | ||
| 21.11. | Auna outlines $500M Mexico expansion and targets out-of-pocket revenue growth amid operational turnaround | 1 | Seeking Alpha | ||
| 21.11. | Auna SAA ADR übertrifft Gewinnprognose für Q3 2025 deutlich, Aktie fällt dennoch | 1 | Investing.com Deutsch | ||
| 20.11. | Auna plant mit Sojitz Expansion im lateinamerikanischen Gesundheitssektor | 5 | Investing.com Deutsch | ||
| AUNA Aktie jetzt für 0€ handeln | |||||
| 20.11. | Auna partners with Sojitz to expand healthcare in Latin America | 2 | Investing.com | ||
| 20.11. | Auna reports Q3 results | 2 | Seeking Alpha | ||
| 20.11. | Auna S.A.: Auna Announces 3Q25 Financial Results | 317 | Business Wire | Auna Delivers Solid Financial and Operating Performance in Peru and Colombia, While Advancing Key Initiatives in Mexico Auna (NYSE: AUNA) ("Auna" or the "Company"), a leading healthcare platform... ► Artikel lesen | |
| 20.11. | Auna S.A.: Auna Announces Strategic Collaboration with Sojitz to Expand Healthcare Access in Latin America | 273 | Business Wire | Auna S.A. ("Auna" or the "Company"), a leading healthcare services provider in Latin America with operations in Mexico, Peru, and Colombia, announced today that Auna and Sojitz Corporation of America... ► Artikel lesen | |
| 20.11. | AUNA S.A. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 19.11. | Earnings Outlook For Auna | 1 | Benzinga.com | ||
| 18.11. | Auna S.A.: Construction License for Torre Trecca Is Granted to EsSalud, Marking Key Milestone in Auna's Public-Private Partnership with the Institution | 282 | Business Wire | Auna S.A. ("Auna" or the "Company"), a leading healthcare services provider in Latin America with operations in Mexico, Peru, and Colombia, announced today that EsSalud, Peru's Social Security System... ► Artikel lesen | |
| 18.11. | JPMorgan downgrades Auna stock to Neutral on slower Mexico growth | 4 | Investing.com | ||
| 18.11. | JPMorgan stuft Auna-Aktie wegen schwächerem Wachstum in Mexiko auf "Neutral" herab | 2 | Investing.com Deutsch | ||
| 07.11. | AUNA S.A. - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 07.11. | Auna S.A.: Auna Announces Completion of US$765 million Debt Refinancing | 271 | Business Wire | Through successful issuance of new Senior Secured 2032 Notes and new Term Loan, Auna extends debt maturities, lowers interest expenses, and enhances short-term liquidity
Auna S.A. ("Auna" or the... ► Artikel lesen | |
| 04.11. | Auna prices $365M senior notes | 1 | Seeking Alpha | ||
| 04.11. | Auna platziert besicherte Anleihe über 365 Millionen US-Dollar mit Fälligkeit 2032 | 2 | Investing.com Deutsch | ||
| 04.11. | Auna prices $365 million in senior secured notes due 2032 | 1 | Investing.com | ||
| 04.11. | Auna S.A.: Auna Announces Successful Pricing of 8.750% Senior Secured Notes Due 2032 | 276 | Business Wire | Auna S.A. (NYSE: AUNA) ("Auna" or the "Company"), a Latin American healthcare company with operations in Mexico, Peru and Colombia, today announced the pricing of U.S.$365,000,000 aggregate principal... ► Artikel lesen | |
| 03.11. | Rückkaufangebot für Anleihen belastet Auna-Aktie | 2 | Investing.com Deutsch |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| PROCEPT BIOROBOTICS | 35,430 | 0,00 % | PROCEPT BioRobotics Reports Third Quarter 2025 Financial Results and Issues 2026 Revenue Guidance | SAN JOSE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 19,400 | 0,00 % | Alignment Healthcare Reports Third Quarter 2025 Results, Surpasses High-End of Guidance Across All Key Metrics | Reports Q3 revenue of $993.7 million, up 43.5% year-over-yearBeats high end of third quarter guidance and raises full-year outlook across all key metrics: membership, revenue, adjusted gross profit... ► Artikel lesen | |
| PROGYNY | 24,150 | 0,00 % | Progyny, Inc. Announces Third Quarter 2025 Results | Reports Revenue of $313.3 Million, Reflecting 9.3% GrowthRaises Full Year Guidance to Reflect Continued Strength in Member EngagementSelling Season Yields Over 80 New Clients, 900,000 New Lives, and... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 43,170 | +1,12 % | EQS-DD: Siemens Healthineers AG: Elisabeth Staudinger-Leibrecht, Kauf | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
28.11.2025 / 17:23... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 40,460 | +1,12 % | Neue 3,250%-Anleihe von Fresenius Medical Care | Stuttgart (www.anleihencheck.de) - Fresenius Medical Care (ISIN DE0005785802/ WKN 578580) hat eine Unternehmensanleihe (ISIN XS3233499089/ WKN A460DH) mit einem Volumen von bis zu 500 Millionen Euro... ► Artikel lesen | |
| GENEDX | 161,95 | 0,00 % | Cathie Wood's ARK sells Iridium, buys GeneDx and WeRide stock | ||
| BETA BIONICS | 30,000 | 0,00 % | Beta Bionics, Inc.: Beta Bionics Reports Third Quarter 2025 Financial Results and Raises Full Year 2025 Guidance | IRVINE, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial... ► Artikel lesen | |
| FRESENIUS | 48,200 | +0,40 % | DZ BANK stuft Fresenius SE auf 'Kaufen' | FRANKFURT (dpa-AFX Analyser) - Die DZ Bank hat den fairen Aktienwert für Fresenius nach den Anfang November vorgelegten Zahlen zum dritten Quartal von 56 auf 57 Euro angehoben. Die Einstufung wurde... ► Artikel lesen | |
| CASTLE BIOSCIENCES | 39,620 | 0,00 % | Castle Biosciences, Inc.: New Data Confirms Performance of DecisionDx-Melanoma to Identify Patients with Less Than Five Percent Risk of Sentinel Lymph Node Positivity | FRIENDSWOOD, Texas, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced new data... ► Artikel lesen | |
| NUTEX HEALTH | 156,79 | 0,00 % | Nutex Health extends share repurchase plan | ||
| BRIGHTSPRING HEALTH SERVICES | 35,160 | 0,00 % | BMO Capital Maintains Bullish 12%+ BrightSpring EBITDA Growth Outlook on Drug Contract Wins, Generic Conversions | ||
| KESTRA MEDICAL TECHNOLOGIES | 24,500 | -5,11 % | Kestra Medical Technologies, Ltd.: Kestra Medical Technologies Reports Preliminary Second Quarter Fiscal 2026 Financial Results | KIRKLAND, Wash., Dec. 01, 2025 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a wearable medical device and digital healthcare company, today reported preliminary financial... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 24,000 | 0,00 % | Privia Health Group, Inc.: Privia Health Reports Third Quarter 2025 Financial Results | Very Strong Third Quarter and Year-to-Date Performance Across the BusinessNet Income +94.1% and Adjusted EBITDA +61.6% compared to 3Q'24Implemented Providers +13.1% and Practice Collections +27.1%... ► Artikel lesen | |
| CERIBELL | 19,150 | 0,00 % | Ceribell Reports Third Quarter 2025 Financial Results | SUNNYVALE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) ("Ceribell"), a medical technology company focused on transforming the diagnosis and management of patients with... ► Artikel lesen | |
| AVEANNA HEALTHCARE | 9,135 | 0,00 % | Aveanna Healthcare stock price target raised to $13 by Raymond James |